Home/Filings/4/0000899243-20-028178
4//SEC Filing

HAUMANN BRETT K 4

Accession 0000899243-20-028178

CIK 0001631650other

Filed

Oct 13, 8:00 PM ET

Accepted

Oct 14, 4:15 PM ET

Size

10.0 KB

Accession

0000899243-20-028178

Insider Transaction Report

Form 4
Period: 2020-10-10
Transactions
  • Disposition to Issuer

    Common Stock, $0.0001 par value

    2020-10-13$34.50/sh13,313$459,2990 total
  • Disposition from Tender

    Common Stock, $0.0001 par value

    2020-10-10$34.50/sh6,250$215,6250 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-10-13$17.39/sh25,453$442,6280 total
    Exercise: $17.11Common Stock (25,453 underlying)
Footnotes (3)
  • [F1]Disposed of to SPN MergerSub, Inc. ("Merger Sub"), which, pursuant to the Agreement and Plan of Merger, dated August 29, 2020, by and between the Issuer, Societes des Produits Nestle S.A., ("Nestle"), and Merger Sub (the "Merger Agreement"), commenced a tender offer to acquire any and all of the outstanding shares of the Issuer's common stock (other than those shares owned by Nestle and its affiliates) at a purchase price of $34.50 per share (the "Offer Price").
  • [F2]Pursuant to the Merger Agreement, each Issuer restricted stock unit ("RSU") that was outstanding immediately prior to the date and time at which the Merger became effective (the "Effective Time") vested in full, terminated, and was converted into the right to receive a cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of common stock subject to the RSU.
  • [F3]Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option.

Issuer

Aimmune Therapeutics, Inc.

CIK 0001631650

Entity typeother

Related Parties

1
  • filerCIK 0001607733

Filing Metadata

Form type
4
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:15 PM ET
Size
10.0 KB